Journal of Surgery Concepts & Practice >

2021 , Vol. 26 >Issue 03: 212 - 216

DOI: https://doi.org/10.16139/j.1007-9610.2021.03.007

Experts forum

Evaluation of liver function in portal hypertension during perioperative stage

Expand

Received date: 2021-03-22

  Online published: 2022-08-03

Fold

Cite this article

CHEN Wei, BU Junfeng . Evaluation of liver function in portal hypertension during perioperative stage[J]. Journal of Surgery Concepts & Practice, 2021 , 26(03) : 212 -216 . DOI: 10.16139/j.1007-9610.2021.03.007

References

[1] 陈皓, 杨卫平, 李宏为. 肝移植时代传统外科手术在肝硬化门静脉高压症中的治疗地位[J]. 外科理论与实践, 2016, 21(5):372-374.
[2] Turco L, Garcia-Tsao G. Portal hypertension: pathogenesis and diagnosis[J]. Clin Liver Dis, 2019, 23(4):573-587.
[3] Tetangco EP, Silva RG, Lerma EV. Portal hypertension: etiology, evaluation, and management[J]. Dis Mon, 2016, 62(12):411-426.
[4] 中华医学会外科学分会门静脉高压症学组. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2015)[J]. 中国实用外科杂志, 2015, 35(10):1086-1090.
[5] 中华医学会外科学分会脾及门静脉高压外科学组. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J]. 中华外科杂志, 2019, 57(12):885-892.
[6] Hackl C, Schlitt HJ, Renner P, et al. Liver surgery in cirrhosis and portal hypertension[J]. World J Gastroenterol, 2016, 22(9):2725-2735.
[7] Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models[J]. Hepatol Int, 2018, 12(Suppl 1):1-10.
[8] 张洁, 曹芸, 王之青, 等. 常规生化指标评估慢性肝功能损害的临床应用价值[J]. 胃肠病学, 2008, 13(10):620-622.
[9] Kew GS, Chen ZJ, Yip AW, et al. Identifying patients with cirrhosis who might avoid screening endoscopy based on serum albumin and bilirubin and platelet counts[J]. Clin Gastroenterol Hepatol, 2021, 19(1):199-201.e2.
[10] Arshad F, Lisman T, Porte RJ. Blood markers of portal hypertension are associated with blood loss and transfusion requirements during orthotopic liver transplantation[J]. Semin Thromb Hemost, 2020, 46(6):751-756.
[11] 付春生, 李庆方. 肝病透明质酸检测与肝功能改变对比分析[J]. 临床荟萃, 2000, 15(7):325-326.
[12] Gudowska M, Gruszewska E, Panasiuk A, et al. Hyaluronic acid concentration in liver diseases[J]. Clin Exp Med, 2016, 16(4):523-528.
[13] 李小侠. 血清谷氨酸脱氢酶与其他肝功能指标联合检测在肝病诊断中的临床意义[J]. 陕西医学杂志, 2020, 49(12):1677-1680.
[14] 罗志江, 彭涛, 林旋, 等. 术前肝功能评估指标的临床应用及研究进展[J/OL]. 中国普外基础与临床杂志, 2021, 1-8.[2021-03-22]. http://kns.cnki.net/kcms/detail/51.1505.R.20210120.0945.002.html.
[15] Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography[J]. J Hepatol, 2017, 67(2):399-411.
[16] 廖玉婷, 邓涛. 超声相关技术在门静脉高压评估中的应用进展[J]. 中国临床研究, 2020, 33(4):560-563,567.
[17] 王鹏昌, 王晓敏, 梁雯雯. 超声造影+超声门静脉血流动力学联合血清指标检测诊断失代偿期肝硬化患者门静脉高压的价值[J]. 中国实用医刊, 2020, 47(19):59-62.
[18] 王静. 超声检查对肝硬化门静脉高压症的诊断价值分析[J]. 影像研究与医学应用, 2017, 1(4):85-86.
[19] Zhao ZL, Wei Y, Wang TL, et al. Imaging and pathological features of idiopathic portal hypertension and diffe-rential diagnosis from liver cirrhosis[J]. Sci Rep, 2020, 10(1):2473.
[20] 吴志勇, 陈炜. 门静脉高压症外科治疗的现状与展望[J]. 中华普通外科杂志, 2010, 25(9):697-701.
[21] 吴志勇, 陈炜. 肝硬化门静脉高压症外科治疗程序[J]. 中国实用外科杂志, 2011, 31(1):39-43.
[22] 吴志勇, 陈炜. 肝硬化门静脉高压症围术期处理策略[J]. 中华消化外科杂志, 2016, 15(7):661-664.
[23] Gharib AM, Han MAT, Meissner EG. Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease[J]. Biomed Res Int, 2017, 2017:2067479.
[24] Wagner M, Hectors S, Bane O, et al. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: preliminary results[J]. J Magn Reson Imaging, 2018, 48(4):1091-1103.
[25] Leung JC, Loong TC, Pang J, et al. Invasive and non-invasive assessment of portal hypertension[J]. Hepatol Int, 2018, 12(Suppl 1):44-55.
[26] Asenbaum U, Ba-Ssalamah A, Mandorfer M, et al. Effects of portal hypertension on gadoxetic acid-enhanced liver magnetic resonance: diagnostic and prognostic implications[J]. Invest Radiol, 2017, 52(8):462-469.
[27] Yoon JH, Lee JM, Paek M, et al. Quantitative assessment of hepatic function: modified look-locker inversion reco-very (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging[J]. Eur Radiol, 2016, 26(6):1775-1782.
[28] Kim YS, Song JS, Kannengiesser S, et al. Comparison of spin-echo echoplanar imaging and gradient recalled echo-based MR elastography at 3 Tesla with and without gadoxetic acid administration[J]. Eur Radiol, 2017, 27(10):4120-4128.
[29] Krige J, Spence RT, Jonas E, et al. A new recalibrated four-category Child-Pugh score performs better than the original Child-Pugh and MELD scores in predicting in-hospital mortality in decompensated alcoholic cirrhotic patients with acute variceal bleeding: a real-world cohort analysis[J]. World J Surg, 2020, 44(1):241-246.
[30] Olevskaya ER, Dolgushina AI, Tarasov AN, et al. Prognosis factors of survival in patients with liver cirrhosis and portal hypertension[J]. Ter Arkh, 2019, 91(2):67-72.
[31] García-Pagán JC, Saffo S, Mandorfer M, et al. Where does TIPS fit in the management of patients with cirrhosis?[J]. JHEP Rep, 2020, 2(4):100122.
[32] 刘晔, 陈炜, 徐庆, 等. 慢性肝病患者肝功能评估方法的研究进展[J]. 诊断学理论与实践, 2010, 9(6):606-610.
[33] Yoshida M, Beppu T, Shiraishi S, et al. (99m)Tc-GSA SPECT/CT fused images for assessment of hepatic function and hepatectomy planning[J]. Ann Transl Med, 2015, 3(2):17.
[34] Garrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis[J]. Ann Surg, 1984, 199(6):648-655.
[35] Mansour A, Watson W, Shayani V, et al. Abdominal ope-rations in patients with cirrhosis: still a major surgical challenge[J]. Surgery, 1997, 122(4):730-735;discussion735-736.
Options
Outlines

/

〈 〉